Saxsons Group — India's trusted nuclear medicine, radiotherapy, oncosurgery, dosimetry and cyclotron supplier since 1986
SortApplication
TherapeuticPeer-ReviewedPubMedPractical radiation oncology · 2026

Practical considerations of gadoxetate disodium contrast in MRI-guided liver SBRT for primary and secondary liver tumors: optimizing image quality and patient throughput.

Kassardjian AA, Maraghechi B, Shi C, Ai H et al.

Purpose/objectivesOptimal implementation of gadoxetate disodium injection (GDI) in liver-directed MR-guided online adaptive radiotherapy (MRgART) remains poorly characterized. Herein, we evaluated the…

Therapeutic📖 Free full textPeer-ReviewedPubMedClinical and translational radiation oncology · 2027

Feasibility of reduced PTV margins in magnetic resonance image-guided online adaptive radiotherapy for bladder cancer: a personalised approach.

Williams B, Sandoughdaran S, Chick J, Dunlop A et al.

IntroductionBladder MRI-guided online adaptive radiotherapy (MRIgART) has enabled a reduction in planning target volume (PTV) margins, reducing normal tissue irradiation. Yet, further margin reduction…

Therapeutic📖 Free full textPeer-ReviewedPubMedFrontiers in oncology · 2026

A prospective pilot study of urine microRNA as a biomarker of urinary radiation toxicity following MRI-guided prostate stereotactic body radiotherapy.

Smyczyńska U, Nowicka Z, Doyle P, Kang H et al.

IntroductionUrinary toxicities are common following prostate radiotherapy and can impair quality of life. New biomarkers are needed that can predict the risk of urinary toxicity following MRI guided s…

TherapeuticPeer-ReviewedPubMedRadiotherapy and oncology · 2026

Early target volume dynamics during MR-guided radiotherapy for glioblastoma: first results from the prospective MARGA-I trial.

Kretzschmar L, Wallimann P, Obergfell LM, Tanadini-Lang S et al.

Serial MRI during radiotherapy may enable early response assessment and guide adaptive treatment strategies; however, data on intratreatment volumetric changes remain limited. We herein report results…

TherapeuticPeer-ReviewedPubMedRadiotherapy and oncology · 2026

Stereotactic MRI-guided adaptive radiation therapy (SMART) for locally advanced pancreatic cancer: A prospective single-center cohort study.

Hartfelt PB, Bisgaard ALH, Ejlsmark MW, Bahij R et al.

PurposeThis prospective single-center cohort study evaluated outcomes and toxicity after ablative stereotactic magnetic resonance imaging (MRI)-guided adaptive radiation therapy (SMART) in patients wi…

QA & dosimetryPeer-ReviewedPubMedPhysics and imaging in radiation oncology · 2026

Six-year data from three magnetic resonance-guided radiotherapy systems demonstrate long-term stability of linear accelerator quality assurance.

Hilgers GC, Woodings SJ, Foppen TA, Wolthaus JWH et al.

Background and purposeMagnetic resonance-guided radiotherapy systems require comprehensive quality assurance (QA) programs to ensure safe and precise treatment delivery. This study evaluates the long-…

Therapeutic📖 Free full textPeer-ReviewedPubMedFrontiers in oncology · 2026

Case Report: MR-guided adaptive stereotactic body radiotherapy for splenic metastases: a case series of technical feasibility and early clinical outcomes.

Tan D, Edwards L, Byrne HL, Liang T et al.

We present a case series of four patients with five splenic metastases treated with stereotactic body radiation therapy (SBRT) using a 1.5-T Unity (Elekta AB, Stockholm, Sweden) magnetic resonance lin…

Therapeutic📖 Free full textPeer-ReviewedPubMedJournal of medical imaging and radiation oncology · 2026

MRI-Guided SBRT Boost for Patients With Locally Advanced Cervical Cancer Who Are Unsuitable for Standard of Care Image-Guided Brachytherapy.

Edwards L, Tan H, Rahim K, Leong E et al.

In recent years, cervical cancer incidence has been on the decline in Australia, likely due to the HPV vaccination and an improved screening programme. However, an estimated 900 new cases will be diag…

Therapeutic📖 Free full textPeer-ReviewedPubMedClinical and translational radiation oncology · 2027

Ablative magnetic resonance-guided radiation for gastrointestinal neuroendocrine tumors: assessing local control and toxicity.

Peterson JS, Goodchild S, Jain S, Bryant JM et al.

BackgroundGastroenteropancreatic neuroendocrine tumors (GEP-NETs) are an indolent subset of neuroendocrine neoplasms with a propensity to metastasize. In the case of oligoprogression, locoregional the…

QA & dosimetry📖 Free full textPeer-ReviewedPubMedPhysics and imaging in radiation oncology · 2026

Real-time tumor tracking for magnetic resonance-guided radiotherapy using label-efficient foundation model adaptation.

Betancourt Tarifa AS, Verheij M, Monshouwer R, Hermans JJ et al.

Background and purposeReal-time tumor tracking on cine magnetic resonance imaging (cine-MRI) enables intra-fraction motion management in magnetic resonance-guided radiotherapy. Pipelines often rely on…

QA & dosimetry📖 Free full textPeer-ReviewedOpenAlexPhysics in Medicine and Biology · 2026

Dosimetric validation of proton beam deflection and field shape deformation in a measured transverse magnetic field of an in-beam MR scanner using a novel dose calculation functionality in a research version of a commercial treatment planning system

Marisa Cobanaj, Franciska Lebbink, Sergej Schneider, Emilia Louisa Ernestine Schäfer et al.

OBJECTIVE: Integrating in-beam magnetic resonance imaging (MRI) with proton therapy (PT) introduces magnetic fields (MFs) that affect proton beam transport and therefore require accurate incorporation…

QA & dosimetry📖 Free full textPeer-ReviewedPubMedTechnology in cancer research & treatment · 2026

Magnetic-Field-Induced Secondary-Electron Effects in MR-Guided Radiotherapy: From Dosimetric Mechanisms to Workflow-Based Clinical Risk Management.

Wang A, Fang J, Tan M, Li Y et al.

MR-guided radiotherapy (MRgRT) combines high-contrast MRI, online adaptation, and radiation delivery in a single treatment workflow. The static magnetic field, however, changes the transport of second…

QA & dosimetryPeer-ReviewedPubMedPhysics and imaging in radiation oncology · 2026

Automated workflow for target volume propagation in online adaptive magnetic resonance guided radiotherapy for lung lesions using foundation models.

Dudas D, Blöcker TJ, Palacios MA, Wei C et al.

Background and purposeThis study presents a novel workflow for automated gross tumor volume (GTV) adaptation in online adaptive magnetic resonance imaging (MRI)-guided radiotherapy using promptable se…

QA & dosimetry📖 Free full textPeer-ReviewedPubMedRadiation oncology (London, England) · 2026

Metal artifact reduction for 3 T MRI-only prostate radiotherapy in patients with hip prostheses: impact on target definition, synthetic CT generation, dose calculation, and fiducial marker identification.

Coskun M, Petersson JS, Wetterstedt SA, Brynolfsson P et al.

Magnetic resonance imaging (MRI) offers superior soft-tissue contrast and MRI-only radiotherapy (RT) eliminates uncertainties associated with computed tomography (CT)-to-MRI image registration. An MRI…

TherapeuticQA & dosimetry📖 Free full textPeer-ReviewedPubMedClinical and translational radiation oncology · 2026

Feasibility of dose accumulation for assessing treatment-related side effects in MR-guided abdominal SABR: A single-institution study.

Shabbir R, Zakacz A, Sivakaran R, Osorio EV et al.

BackgroundDaily adaptive magnetic resonance (MR)-guided treatment changes delivered dose distributions, making cumulative dose uncertain. This work assessed the feasibility of exploring potential rela…

QA & dosimetry📖 Free full textPeer-ReviewedPubMedJournal of applied clinical medical physics · 2026

Evaluation of inter-fractional anatomical variations due to compression belt placement reproducibility using MR-guided radiotherapy treatment fraction images.

Shay O, Solis D, Aire M, Schneider C et al.

BackgroundAbdominal compression (AC) using a belt-based system is widely employed in radiation therapy to limit respiration-induced target motion for abdominal and hepatic malignancies. While AC has d…

QA & dosimetry📖 Free full textPeer-ReviewedPubMedPhysics and imaging in radiation oncology · 2026

Uncertainty estimation for reliable neural network-based radiotherapy dose modelling using Monte Carlo dropout, mean variance estimation and deep ensemble.

Schneider M, Eberhardt T, Gani C, Fischer P et al.

Background and purposeNeural networks promise fast dose modelling with high accuracy for challenging situations like magnetic resonance imaging (MRI)-guided radiotherapy. As they are data-driven, fail…

Therapeutic📖 Free full textPeer-ReviewedPubMedInternational journal of radiation oncology, biology, physics · 2026

MRI-Guided Reduced-Volume RT for Early-Stage Glottic Cancer: A Prospective Phase 1 Trial with Quantification of Laryngeal Motion.

Leeman JE, Droznin AD, Dwyer CD, Shin KY et al.

Five to 7 weeks of whole-larynx radiation (RT) is standard for treatment of early-stage glottic cancer. Previous studies evaluated CT-guided hypofractionated/SBRT treatment to a smaller volume. Magnet…

Therapeutic📖 Free full textPeer-ReviewedOpenAlexCurrent Oncology · 2026

Initial Experience with MR-Guided or CT-Guided Stereotactic Body Radiotherapy for Prostate Cancer

Marc Vincent Barcelona, Noelia Sanmamed, Enrique Gutierrez Valencia, Alejandro Berlín et al.

We report early toxicity outcomes after institutional implementation of prostate SBRT using 42.7 Gy in seven fractions delivered with either MR-guided adaptive SBRT (MRgSBRT) or CT-guided non-adaptive…

QA & dosimetry📖 Free full textPeer-ReviewedOpenAlexJournal of Applied Clinical Medical Physics · 2026

Log file‐based patient‐specific quality assurance for MR‐guided radiation therapy with comprehensive motion management

Kai Yuan, Matthew M. Cheung, Louis Lee

BACKGROUND: Patient-Specific Quality Assurance (PSQA) for Elekta Unity MR-Linac treatments delivered under Comprehensive Motion Management (CMM) is challenging because beam gating, unexpected interrup…

QA & dosimetry📖 Free full textPeer-ReviewedPubMedRadiological physics and technology · 2026

Development of a CT/MRI-compatible anthropomorphic multimodal deformable male pelvic phantom for end-to-end quality assurance testing in MR-guided online adaptive radiotherapy.

Nishitani M, Okamoto H, Chang W, Kuwahara J et al.

Current quality assurance phantoms often lack MR signal, deformability, or real-time dosimetry capability, limiting comprehensive end-to-end evaluation for MR-guided online adaptive radiotherapy (MRgO…

QA & dosimetry📖 Free full textPeer-ReviewedOpenAlexVCU Scholars Compass (Virginia Commonwealth University) · 2026

Generating Synthetic CT from MRI Data

Foysal Ahmed

Magnetic resonance imaging (MRI) provides excellent soft tissue contrast without ionizing radiation, making it a strong alternative to computed tomography (CT) in medical imaging workflows. However, C…

Therapeutic📖 Free full textPeer-ReviewedOpenAlexThe Oncologist · 2026

IUC25511-7 MERIT AWARD: Prostate volume changes during longer fractionated and ultra-hypofractionated MR-guided adaptive radiotherapy leveraging the MOMENTUM registry

S Cooper, H Akhiat, S Alexander, F Alongi et al.

Abstract Background Prostate volume changes during radiotherapy may compromise target coverage. We quantified longitudinal swelling across longer fractionation (≥15 fractions)(LFRT) and stereotactic b…

TherapeuticPeer-ReviewedPubMedClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026

Biologically adaptive radiation oncology in oligometastatic and oligoprogressive disease: MR- and CBCT-guided adaptation, molecular imaging, dose painting, biomarkers, and AI.

Tariq H, Afzal T, Khan A.

Oligometastatic disease (OMD) and oligoprogression are clinically actionable states in which local treatment of limited tumour burden can prolong disease control for selected patients. Randomised phas…

Showing the 60 most recent of 168 papers in this topic.Browse every paper →